|
RNASEH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.64029994826387E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.16329999966247E-07 |
| Normal-vs-Stage2 |
5.80919999992879E-07 |
| Normal-vs-Stage3 |
2.54070000038631E-07 |
| Normal-vs-Stage4 |
4.38780000000527E-05 |
| Stage1-vs-Stage2 |
3.018400E-01 |
| Stage1-vs-Stage3 |
9.650400E-01 |
| Stage1-vs-Stage4 |
7.923000E-01 |
| Stage2-vs-Stage3 |
2.922800E-01 |
| Stage2-vs-Stage4 |
2.826800E-01 |
| Stage3-vs-Stage4 |
8.180000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.0284999996113E-07 |
| Normal-vs-AfricanAmerican |
3.479100E-03 |
| Normal-vs-Asian |
4.88630000017309E-07 |
| Caucasian-vs-AfricanAmerican |
5.161800E-01 |
| Caucasian-vs-Asian |
2.739600E-01 |
| AfricanAmerican-vs-Asian |
1.610990E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.06609976191896E-10 |
| Normal-vs-Female |
1.76749999969417E-07 |
| Male-vs-Female |
4.132000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.20140000003932E-06 |
| Normal-vs-Age(41-60Yrs) |
2.38300001953462E-09 |
| Normal-vs-Age(61-80Yrs) |
4.04599999948019E-07 |
| Normal-vs-Age(81-100Yrs) |
5.581800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.072200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.095400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.575600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.671600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.296600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.050800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.466400E-01 |
| Classical-VS-Follicular |
3.189800E-04 |
| Classical-VS-Other |
2.614000E-02 |
| Classical-VS-Normal |
4.5345999999391E-07 |
| Tall-VS-Follicular |
9.335700E-03 |
| Tall-VS-Other |
1.271950E-02 |
| Tall-VS-Normal |
1.322950E-03 |
| Follicular-VS-Other |
3.991400E-01 |
| Follicular-VS-Normal |
1.23279997321646E-09 |
| Other-VS-Normal |
6.20889999999319E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.45430001374791E-09 |
| Normal-vs-N1 |
1.85697999999235E-05 |
| N0-vs-N1 |
7.525600E-01 |
|
|
